(Q37332276)

19 August 2017

1 reference

title

Efficient identification and evaluation of effective Helicobacter pylori therapies (English)

1 reference

Helicobacter pylori infectious disease

19 August 2017

0 references

1 reference

1

David Y Graham

1 reference

19 August 2017

PMCID

2838433

language of work or name

English

0 references

publication date

30 October 2008

1 reference

Clinical Gastroenterology and Hepatology

19 August 2017

1 reference

19 August 2017

7

1 reference

19 August 2017

2

1 reference

19 August 2017

145-148

1 reference

New concepts of resistance in the treatment of Helicobacter pylori infections

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Vitamin B12 deficiency and gastric histopathology in older patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

6 September 2017

Gastropathic sideropenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Pharmacokinetic considerations in the eradication of Helicobacter pylori

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Optimal two-stage designs for phase II clinical trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Sequential regimens for Helicobacter pylori eradication

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

Iron deficiency and Helicobacter pylori infection in the United States

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838433

One-sample multiple testing procedure for phase II clinical trials

2 September 2018

1 reference

12 December 2020

Optimal three-stage designs for phase II cancer clinical trials

1 reference

12 December 2020

A report card to grade Helicobacter pylori therapy

1 reference

12 December 2020

An optimal three-stage design for phase II clinical trials

1 reference

12 December 2020

10.1016/J.CGH.2008.10.024

Identifiers

DOI

1 reference

release_4nnxal6oajdjdfbjn6jqp2m2ty

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4nnxal6oajdjdfbjn6jqp2m2ty

24 November 2022

mapped directly with Wikidata item

PMCID

2838433

1 reference

19 August 2017

1 reference

PMCID

2838433